Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto

BACKGROUND: The incidence of central nervous system (CNS) metastases in breast cancer patients is rising and has become a major clinical challenge. Only few data are published concerning risk factors for the development of CNS metastases as a first site of metastatic disease in breast cancer patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Laakmann, Elena, Witzel, Isabell, Fasching, Peter A., Rezai, Mahdi, Schem, Christian, Solbach, Christine, Tesch, Hans, Klare, Peter, Schneeweiss, Andreas, Salat, Christoph, Zahm, Dirk-Michael, Blohmer, Jens-Uwe, Ingold-Heppner, Barbara, Huober, Jens, Hanusch, Claus, Jackisch, Christian, Reinisch, Mattea, Untch, Michael, von Minckwitz, Gunter, Nekljudova, Valentina, Müller, Volkmar, Loibl, Sibylle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509843/
https://www.ncbi.nlm.nih.gov/pubmed/31077239
http://dx.doi.org/10.1186/s13058-019-1144-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509843/
https://www.ncbi.nlm.nih.gov/pubmed/31077239
http://dx.doi.org/10.1186/s13058-019-1144-x

Ejemplares similares